Exhibit 99.1

 

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION

 

Introduction

 

On September 25, 2022, Inpixon (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, KINS Technology Group Inc., a Delaware corporation (“KINS”), CXApp Holding Corp., a Delaware corporation and newly formed wholly-owned subsidiary of Inpixon (“CXApp” and, together with Inpixon, collectively, the “Companies”), and KINS Merger Sub Inc., a Delaware corporation and a wholly-owned subsidiary of KINS (“Merger Sub”), pursuant to which KINS will acquire Inpixon’s enterprise apps business (including its workplace experience technologies, indoor mapping, events platform, augmented reality and related business solutions) (the “Enterprise Apps Business”) in exchange for the issuance of shares of KINS capital stock valued at $69 million (the “Business Combination”) to be issued to Inpixon stockholders.

 

The Merger Agreement, along with the Separation Agreement and the other transaction documents to be entered into in connection therewith, provides for, among other things, the consummation of the following transactions: (i) Inpixon will transfer the Enterprise Apps Business (the “Separation”) to its wholly-owned subsidiary, CXApp, and contribute $10 million in cash (the “Cash Contribution”), (ii) following the Separation, Inpixon will distribute 100% of the shares of CXApp Common Stock to Inpixon stockholders and other security holders by way of the Distribution and (iii) following the completion of the foregoing transactions and subject to the satisfaction or waiver of certain other conditions set forth in the Merger Agreement, the parties shall consummate the Merger. The Separation, Distribution and Merger are intended to qualify as “tax-free” transactions.

 

The following unaudited pro forma condensed consolidated financial information is presented in accordance with the rules specified by Article 11 of Regulation S-X promulgated by the U.S. Securities and Exchange Commission (the “SEC”) and has been prepared subject to the assumptions and adjustments as described in the notes thereto. Specifically, the unaudited pro forma condensed consolidated financial information set forth below reflects the effects of the Business Combination on (i) the Company’s condensed consolidated balance sheet as of June 30, 2022, as if the Business Combination had occurred on that date, and (ii) Company’s condensed consolidated statement of operations for the six months ended June 30, 2022, and the year ended December 31, 2021, as if the Business Combination had occurred on January 1, 2021. Management believes that the assumptions used, and adjustments made are reasonable under the circumstances and given the information available.

 

The following unaudited pro forma condensed consolidated financial statements have been derived from historical financial statements prepared in accordance with U.S. generally accepted accounting principles (“US GAAP”). The pro forma adjustments reflect the impacts of events directly attributable to the Business Combination, that are factually supportable, and for purposes of the unaudited pro forma condensed consolidated statements of operations, expected to have a continuing impact on the Company. The following unaudited proforma condensed consolidated financial information is for illustrative and informational purposes only and is not necessarily indicative of the financial condition or results of operations of the Company that would have occurred if the Business Combination had occurred on the dates indicated, nor is it indicative of the future financial condition or results of operations of the Company.

 

The unaudited pro forma condensed consolidated financial information should be read in conjunction with the following:

 

The accompanying notes to the unaudited pro forma condensed consolidated financial statements;
The Company’s unaudited condensed consolidated financial statements as of and for the six months ended June 30, 2022, included in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2022; and
The Company’s audited consolidated financial statements as of and for the year ended December 31, 2021, included in its Annual Report on Form 10-K for the year ended December 31, 2021.

 

The historical condensed consolidated statement of operations for the year ended December 31, 2021, has been adjusted by Company management to reflect certain reclassifications to conform with current financial statement presentation.

 

 

 

 

INPIXON AND SUBSIDIARIES

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET

As of June 30, 2022

(In thousands, except number of shares and par value data)

 

   Inpixion and
Subsidiaries
Historical
(a)
   Pro Forma
Adjustments
   Note  Inpixion and
Subsidiaries Pro
Forma
 
                
Assets                  
                   
Current Assets                  
Cash and cash equivalents  $65,755   $(10,000)  (c), (d)  $55,755 
Accounts receivable, net of allowances   2,767    (1,231)  (c)   1,536 
Other receivables   311    (36)  (c)   275 
Inventory   1,581    (10)  (c)   1,571 
Note receivable   5,967    -       5,967 
Prepaid expenses and other current assets   3,463    (1,503)  (c)   1,960 
                   
Total Current Assets   79,844    (12,780)      67,064 
                   
Property and equipment, net   1,348    (215)  (c)   1,133 
Operating lease right-of-use asset, net   1,582    (847)  (c)   735 
Software development costs, net   1,647    (562)  (c)   1,085 
Investments in equity securities   582    6,090   (e)   6,672 
Long-term investments   2,500    (2,500)  (e)   - 
Intangible assets, net   30,126    (21,450)  (c)   8,676 
Other assets   217    (53)  (c)   164 
                   
Total Assets  $117,846   $(32,317)     $85,529 
                   
Liabilities and Stockholders’ Equity                  
                   
Current Liabilities                  
Accounts payable  $900   $(327)  (c)   573 
Accrued liabilities   4,116    (2,087)  (c)   2,029 
Operating lease obligation, current   600    (266)  (c)   334 
Deferred revenue   3,638    (2,452)  (c)   1,186 
Short-term debt   1,911    -       1,911 
Acquisition liability   3,486    -       3,486 
                   
Total Current Liabilities   14,651    (5,132)      9,519 
                   
Long Term Liabilities                  
Operating lease obligation, noncurrent   1,022    (602)  (c)   420 
Other liabilities, noncurrent   28    (30)  (c)   (2)
                   
Total Liabilities   15,701    (5,764)      9,937 
                   
Commitments and Contingencies                  
                   
Mezzanine Equity                  
Series 8 Convertible Preferred Stock- 53,197.7234 shares authorized; 53,197.7234 issued and outstanding as of June 30, 2022, respectively. (Liquidation preference of $53,197,723)   48,158    -       48,158 
                   
Stockholders’ Equity                  
Common Stock - $0.001 par value; 26,666,667 shares authorized; 2,068,080 issued and 2,068,079 outstanding as of June 30, 2022, respectively.   2    -   (f)   2 
Additional paid-in capital   334,589    -       334,589 
Treasury stock, at cost, 1 share   (695)   -       (695)
Accumulated other comprehensive income   598    -       598 
Accumulated deficit   (281,463)   (26,553)  (c), (d), (e)   (308,016)
                   
Stockholders’ Equity Attributable to Inpixon   53,031    (26,553)      26,478 
                   
Non-controlling Interest   956    -       956 
                   
Total Stockholders’ Equity   53,987    (26,553)      27,434 
                   
Total Liabilities, Mezzanine Equity and Stockholders’ Equity  $117,846   $(32,317)     $85,529 

 

The accompanying notes are an integral part of these unaudited pro forma condensed consolidated financial statements.

 

2

 

 

INPIXON AND SUBSIDIARIES

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the six months ended June 30, 2022

(In thousands, except number of shares and par value data)

 

   Inpixion and
Subsidiaries
Historical
(a)
   Pro Forma
Adjustments
   Note  Inpixion and
Subsidiaries Pro
Forma
 
Revenues  $9,956   $(4,731)  (g)  $5,225 
                   
Cost of Revenues   2,782    (1,129)  (g)   1,653 
                   
Gross Profit   7,174    (3,602)      3,572 
                   
Operating Expenses                  
Research and development   8,997    (4,421)  (g)   4,576 
Sales and marketing   4,600    (2,676)  (g), (h)   1,924 
General and administrative   13,002    (853)  (g), (h)   12,149 
Acquisition-related costs   268    (16)  (g)   252 
Impairment of goodwill   7,570    (5,540)  (g)   2,030 
Amortization of intangibles   2,691    (1,948)  (g)   743 
                   
Total Operating Expenses   37,128    (15,454)      21,674 
                   
Loss from Operations   (29,954)   11,852       (18,102)
                   
Other Income (Expense)                  
Interest income (expense), net   178    (9)  (g)   169 
Other expense, net   (771)   234   (g)   (537)
Unrealized loss on equity securities   (1,256)   -       (1,256)
Total Other Expense   (1,849)   225       (1,624)
                   
Net Loss, before tax   (31,803)   12,077       (19,726)
Income tax provision   (84)   62   (g)   (22)
Net Loss   (31,887)   12,139       (19,748)
                   
Net Loss Attributable to Non-controlling Interest   (804)   -       (804)
                   
Net Loss Attributable to Stockholders of Inpixon   (31,083)   12,139       (18,944)
Accretion of Series 7 preferred stock   (4,555)   -       (4,555)
Accretion of Series 8 Preferred Stock   (6,785)   -       (6,785)
Deemed dividend for the modification related to Series 8 Preferred Stock   (2,627)   -       (2,627)
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock   1,469    -       1,469 
Amortization premium- modification related to Series 8 Preferred Stock   1,362    -       1,362 
Net Loss Attributable to Common Stockholders  $(42,219)  $12,139      $(30,080)
Basic and diluted loss per share  $(21.68)       (f)  $(15.45)
Weighted Average Shares Outstanding, basic and diluted   1,947,365        (f)   1,947,365 

 

The accompanying notes are an integral part of these unaudited pro forma condensed consolidated financial statements.

 

3

 

 

INPIXON AND SUBSIDIARIES

UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the year ended December 31, 2021

(In thousands, except number of shares and par value data)

 

   Inpixion and
Subsidiaries
Historical
(b)
   Pro Forma
Adjustments
   Note  Inpixion and
Subsidiaries Pro
Forma
 
Revenues  $15,995   $(6,368)  (g)  $9,627 
                   
Cost of Revenues   4,374    (1,646)  (g)   2,728 
                   
Gross Profit   11,621    (4,722)      6,899 
                   
Operating Expenses                  
Research and development   14,121    (6,704)  (g)   7,417 
Sales and marketing   8,261    (4,763)  (g), (h)   3,498 
General and administrative   41,352    (21,137)  (g), (h)   20,215 
Acquisition-related costs   1,248    (628)  (g)   620 
Impairment of goodwill   14,789    (11,896)  (g)   2,893 
Amortization of intangibles   4,467    (3,047)  (g)   1,420 
                   
Total Operating Expenses   84,238    (48,175)      36,063 
                   
Loss from Operations   (72,617)   43,453       (29,164)
                   
Other Income (Expense)                  
Interest income, net   1,183    (1)  (g)   1,182 
Loss on exchange of debt for equity   (30)   -       (30)
Benefit for valuation allowance on related party loan - held for sale   7,345    -       7,345 
Other expense, net   (173)   (81)  (g)   (254)
Gain on related party loan - held for sale   49,817    -       49,817 
Unrealized loss on equity securities   (57,067)   -       (57,067)
Total Other Income   1,075    (82)      993 
                   
Net Loss, before tax   (71,542)   43,371       (28,171)
Income tax benefit (provision)   1,412    (2,527)  (g)   (1,115)
Net Loss   (70,130)   40,844       (29,286)
                   
Net Loss Attributable to Non-controlling Interest   (975)   -       (975)
                   
Net Loss Attributable to Stockholders of Inpixon   (69,155)   40,844       (28,311)
Accretion of Series 7 preferred stock   (8,161)   -       (8,161)
Net Loss Attributable to Common Stockholders  $(77,316)  $40,844      $(36,472)
Basic and diluted loss per share  $(53.70)       (f)  $(25.33)
Weighted Average Shares Outstanding, basic and diluted   1,439,753        (f)   1,439,753 

 

The accompanying notes are an integral part of these unaudited pro forma condensed consolidated financial statements.

 

4

 

 

INPIXON AND SUBSIDIARIES

NOTES TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION

 

(1)Basis of presentation

 

The unaudited pro forma condensed financial statements are based on the historical consolidated financial statements of the seller as adjusted to give effect to the Separation. The unaudited pro forma condensed consolidated statements of operations for the six months ended June 30, 2022, and the year ended December 31, 2021, give effect to the Separation as if it were completed on January 1, 2021. The unaudited pro forma condensed consolidated balance sheet as of June 30, 2022, gives effect to the Separation as if it were completed on June 30, 2022. The transaction accounting adjustments for the Separation consist of those necessary to account for the Separation.

 

(2)Unaudited Pro Forma Adjustments

 

The following is a summary of the unaudited pro forma adjustments reflected in the unaudited pro forma condensed consolidated financial statements based on preliminary estimates, which may change as additional information is obtained.

 

a.Reflects amounts as originally reported by the Company in its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022.

 

b.Reflects amounts as originally reported by the Company in its Annual Report on Form 10-K for the year ended December 31, 2021.

 

c.Reflects the elimination of the Enterprise Apps Business assets, liability and historical equity balances including within the Company’s consolidated financial statements. The amount of the actual gain will be calculated based on the net book value of the sold business as of the closing of the Business Combination and therefore could differ from the current estimate.

 

d.Reflects adjustment for remaining cash contribution of $3.8 million agreed upon within the Separation agreement.

 

e.Reflects adjustment for the stepped-up value of Inpixon’s investment in Class A and Class B Units of Cardinal Ventures Holdings LLC, which has certain interests in the sponsor of KINS. As such, Inpixon is entitled to an allocation of financial instruments distributed; assuming all public shareholders redeem as a result of the business combination Inpixon expects to receive 600,000 Class A shares of KINS and 2,500,000 private warrants. This results in an investment in equity securities of approximately $6.1 million assuming a $10.00 per share prices and an estimated value of the private warrants being determined based on a trading price of $0.036 per share as of October 14, 2022.

 

f.Reflects adjustment for reverse stock split of the Company’s authorized and issued and outstanding shares of common stock at a ratio of one (1) share of common stock for every seventy five (75) shares of common stock. The Company executed the reverse stock split on October 7, 2022.

 

g.Reflects the elimination of the historical revenues and expenses directly to related to the Enterprise Apps Business that will not recur in the Company’s consolidated statement of operations beyond a year from the date of the Business Combination.

 

h.Reflects management’s estimate of approximately $1.1 million and $.6 million of historical costs mainly executive salaries and benefits in general and administrative and sales and marketing expenses to replace shared personnel that were allocated to the Enterprise Apps Business that are needed to run the Company on a stand-alone basis added back to the statement of operations for the year ended December 31, 2021 and for the six months ended June 30, 2022, respectively.

 

 

5